NEW YORK (GenomeWeb) – CombiMatrix today announced that the New York State Department of Health has approved the firm's CombiSNP Array for Prenatal Diagnosis.

The CombiSNP Array uses chromosomal microarray analysis of chorionic villi and amniocentesis samples to detect chromosomal imbalances not detected by karyotyping.

"The prenatal diagnostic test we offer is important both as a first-tier test and as a tool physicians utilize to confirm the increasing number of positive non-invasive prenatal screening results," CombiMatrix CEO Mark McDonough said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.